1. Home
  2. GRWG vs ALDX Comparison

GRWG vs ALDX Comparison

Compare GRWG & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

HOLD

Current Price

$1.42

Market Cap

89.6M

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

BUY

Current Price

$0.64

Market Cap

88.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GRWG
ALDX
Founded
2008
2004
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.6M
88.1M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
GRWG
ALDX
Price
$1.42
$0.64
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$2.50
★ $6.60
AVG Volume (30 Days)
258.4K
★ 1.8M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.22
40.43
EPS
★ N/A
N/A
Revenue
★ $193,365,479.00
N/A
Revenue This Year
$2.59
N/A
Revenue Next Year
$5.33
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 142.51
N/A
52 Week Low
$1.01
$0.65
52 Week High
$2.40
$5.93

Technical Indicators

Market Signals
Indicator
GRWG
ALDX
Relative Strength Index (RSI) 37.34 26.26
Support Level $1.28 N/A
Resistance Level $1.62 $1.91
Average True Range (ATR) 0.05 0.10
MACD -0.01 -0.02
Stochastic Oscillator 21.05 0.02

Price Performance

Historical Comparison
GRWG
ALDX

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: